BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1363 related articles for article (PubMed ID: 14696433)

  • 21. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
    Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
    Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.
    Van Hazel G; Blackwell A; Anderson J; Price D; Moroz P; Bower G; Cardaci G; Gray B
    J Surg Oncol; 2004 Nov; 88(2):78-85. PubMed ID: 15499601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic arterial infusion alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer.
    Kim JC; Kim HC; Lee KH; Yu CS; Kim TW; Chang HM; Ryu MH; Kim JH; Ha HK; Lee MG
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1026-35. PubMed ID: 16724990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study.
    Tono T; Hasuike Y; Ohzato H; Takatsuka Y; Kikkawa N
    Cancer; 2000 Apr; 88(7):1549-56. PubMed ID: 10738212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer.
    Qin B; Kato K; Mitsugi K; Nakamura M; Tanaka R; Baba E; Ariyama H; Kuroiwa T; Harada M; Nakano S
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):114-9. PubMed ID: 16001177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for unresectable liver metastases from colorectal cancer].
    Yamashita K; Urakami A; Kubota H; Nagatsuka R; Murakami H; Kawabe Y; Higashida M; Hirabayashi Y; Mikami Y; Ikeda M; Fuchimoto M; Yamamura M; Oka Y; Okumura H; Iki K; Matsumoto H; Imai S; Hirai T; Tsunoda T
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):71-6. PubMed ID: 18195531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation.
    van Iersel LB; Verlaan MR; Vahrmeijer AL; van Persijn van Meerten EL; Tijl FG; Sparidans RW; Gelderblom H; Kuppen PJ; Tollenaar RA; van de Velde CJ
    Eur J Surg Oncol; 2007 Sep; 33(7):874-81. PubMed ID: 17400422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
    Hendlisz A; Van den Eynde M; Peeters M; Maleux G; Lambert B; Vannoote J; De Keukeleire K; Verslype C; Defreyne L; Van Cutsem E; Delatte P; Delaunoit T; Personeni N; Paesmans M; Van Laethem JL; Flamen P
    J Clin Oncol; 2010 Aug; 28(23):3687-94. PubMed ID: 20567019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility.
    Guthoff I; Lotspeich E; Fester C; Wallin I; Schatz M; Ehrsson H; Kornmann M
    Anticancer Res; 2003; 23(6D):5203-8. PubMed ID: 14981990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined therapy with radiofrequency thermal ablation and intra-arterial infusion chemotherapy for hepatic metastases from colorectal cancer.
    Kainuma O; Asano T; Aoyama H; Takayama W; Nakagohri T; Kenmochi T; Hasegawa M; Tokoro Y; Sasagawa S; Ochiai T
    Hepatogastroenterology; 1999; 46(26):1071-7. PubMed ID: 10370669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Continuous hepatic arterial infusion of fluorouracil with leucovorin for liver metastases from colorectal cancer].
    Yamamura T; Matsuzaki H; Hashizume R; Arifuku T; Adachi Y; Nagaoka S; Kimura M; Akaishi O; Tsukikawa S
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1691-4. PubMed ID: 9382508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multicenter phase II study of the Liver Metastases Study Group of weekly intra-arterial 24-hour high dose therapy with 5-FU and folinic acid (FA) in liver metastases of colorectal tumors].
    Staib-Sebler E; Müller HH; Mattes P; Junginger T; Saeger HD; Lorenz M
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1441-4. PubMed ID: 9931906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic arterial infusion of 5-fluorouracil and extrabeam radiotherapy for liver metastases from pancreatic carcinoma.
    Ishii H; Furuse J; Nagase M; Yoshino M; Kawashima M; Satake M; Ogino T; Ikeda H
    Hepatogastroenterology; 2004; 51(58):1175-8. PubMed ID: 15239272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intra-arterial (5-FU/FA and FUDR) versus systemic chemotherapy (5-FU/FA) of non-resectable colorectal liver metastases].
    Gassel HJ; Müller HH; Mattes P; Stieger R; Schramm H; Lorenz M
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1458-60. PubMed ID: 9931911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carcinoembryonic antigen and intra-arterial chemotherapy response of liver metastases.
    Hanazaki K; Kawamura N; Sodeyama H; Wakabayashi M; Yokoyama S; Sode Y; Miyazaki T; Okazaki Y
    Hepatogastroenterology; 1998; 45(20):462-7. PubMed ID: 9638428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S
    J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.